Related Experiment Video
Updated: Feb 3, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus
Nadishka Jayawardena1, Laura N Burga1, Richard A Easingwood2
1Department of Microbiology and Immunology, University of Otago, 9054 Dunedin, New Zealand.
Abstract:
Recently, the use of oncolytic viruses in cancer therapy has become a realistic therapeutic option. Seneca Valley Virus (SVV) is a newly discovered picornavirus, which has earned a significant reputation as a potent oncolytic agent. Anthrax toxin receptor 1 (ANTXR1), one of the cellular receptors for the protective antigen secreted by Bacillus anthracis, has been identified as the high-affinity cellular receptor for SVV. Here, we report the structure of the SVV-ANTXR1 complex determined by single-particle cryo-electron microscopy analysis at near-atomic resolution. This is an example of a shared receptor structure between a mammalian virus and a bacterial toxin. Our structure shows that ANTXR1 decorates the outer surface of the SVV capsid and interacts with the surface-exposed BC loop and loop II of VP1, "the puff" of VP2 and "the knob" of VP3. Comparison of the receptor-bound capsid structure with the native capsid structure reveals that receptor binding induces minor conformational changes in SVV capsid structure, suggesting the role of ANTXR1 as an attachment receptor. Furthermore, our results demonstrate that the capsid footprint on the receptor is not conserved in anthrax toxin receptor 2 (ANTXR2), thereby providing a molecular mechanism for explaining the exquisite selectivity of SVV for ANTXR1.
Insights
Seneca Valley Virus (SVV), a potent oncolytic virus, binds to Anthrax toxin receptor 1 (ANTXR1). This structural study reveals how SVV uses ANTXR1 for cancer therapy, showing specific binding interactions.
Area of Science:
- Structural biology
- Virology
- Cancer therapy
Background:
- Oncolytic viruses are emerging as a viable cancer treatment.
- Seneca Valley Virus (SVV) is a promising oncolytic agent.
- Anthrax toxin receptor 1 (ANTXR1) is the identified receptor for SVV.
Purpose of the Study:
- To determine the near-atomic resolution structure of the SVV-ANTXR1 complex.
- To elucidate the molecular interactions between SVV and its receptor ANTXR1.
- To understand the basis for SVV's selective binding to ANTXR1.
Main Methods:
- Single-particle cryo-electron microscopy (cryo-EM) was used to determine the complex structure.
- Comparative analysis of receptor-bound and native SVV capsid structures was performed.
- Molecular interactions at the interface of SVV and ANTXR1 were analyzed.
Main Results:
- The structure of the SVV-ANTXR1 complex was resolved at near-atomic resolution.
- ANTXR1 binds to specific sites on the SVV capsid, including loops and knobs on viral proteins (VP1, VP2, VP3).
- Receptor binding induces minimal conformational changes in the SVV capsid, indicating ANTXR1's role as an attachment receptor.
Conclusions:
- The study provides a detailed structural mechanism for SVV binding to ANTXR1.
- The findings highlight a shared receptor between a virus and a bacterial toxin.
- The structural basis for SVV's selective binding to ANTXR1 over ANTXR2 is explained, offering insights for oncolytic virus design.
More Related Videos
06:44Confocal Imaging of Double-Stranded RNA and Pattern Recognition Receptors in Negative-Sense RNA Virus Infection
Published on: January 26, 2019
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Related Concept Videos
What are Viruses?
Olfactory Receptors: Location and Structure
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Internal Receptors
Viral Structure